IL-2 receptors, NK and LAK cytotoxicity of lymphocytes in breast carcinoma during prolonged thymopentin therapy

J Nucl Med Allied Sci. 1990 Oct-Dec;34(4 Suppl):161-2.

Authors

C Mazzarino¹, A Nicosia, V Monte, S Petralia, C Garraffo, A Girlando, S Santoro, G Malaponte

Affiliation

¹ General Pathology Institute, University of Catania.

PMID: 2128707

No abstract available

MeSH terms

Breast Neoplasms / drug therapy
Breast Neoplasms / immunology*
Cytotoxicity, Immunologic / drug effects*
Humans
Killer Cells, Natural / immunology*
Long-Term Care
Receptors, Interleukin-2 / blood*
Thymopentin / pharmacology*
Thymopentin / therapeutic use

Substances

Receptors, Interleukin-2
Thymopentin